Canavan disease: mutations among Jewish and non-jewish patients (original) (raw)

Abstract

Canavan disease is an autosomal recessive leukodystrophy caused by the deficiency of aspartoacylase (ASPA). Sixty-four probands were analyzed for mutations in the ASPA gene. Three point mutations--693C-->A, 854A-->C, and 914C-->A--were identified in the coding sequence. The 693C-->A and 914C-->A base changes, resulting in nonsense tyr231-->ter and missense ala305-->glu mutations, respectively, lead to complete loss of ASPA activity in in vitro expression studies. The 854A-->C transversion converted glu to ala in codon 285. The glu285-->ala mutant ASPA has 2.5% of the activity expressed by the wild-type enzyme. A fourth mutation, 433 --2(A-->G) transition, was identified at the splice-acceptor site in intron 2. The splice-site mutation would lead to skipping of exon 3, accompanied by a frameshift, and thus would produce aberrant ASPA. Of the 128 unrelated Canavan chromosomes analyzed, 88 were from probands of Ashkenazi Jewish descent. The glu285-->ala mutation was predominant (82.9%) in this population, followed by the tyr231-->ter (14.8%) and 433 --2(A-->G) (1.1%) mutations. The three mutations account for 98.8% of the Canavan chromosomes of Ashkenazi Jewish origin. The ala305-->glu mutation was found exclusively in non-Jewish probands of European descent and constituted 60% of the 40 mutant chromosomes. Predominant occurrence of certain mutations among Ashkenazi Jewish and non-Jewish patients with Canavan disease would suggest a founding-father effect in propagation of these mutant chromosomes.

34

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adachi M., Schneck L., Cara J., Volk B. W. Spongy degeneration of the central nervous system (van Bogaert and Bertrand type; Canavan's disease). A review. Hum Pathol. 1973 Sep;4(3):331–347. doi: 10.1016/s0046-8177(73)80098-x. [DOI] [PubMed] [Google Scholar]
  2. Adachi M., Torii J., Schneck L., Volk B. W. Electron microscopic and enzyme histochemical studies of the cerebellum in spongy degeneration (van Bogaert and Bertrans type). Acta Neuropathol. 1972;20(1):22–31. doi: 10.1007/BF00687899. [DOI] [PubMed] [Google Scholar]
  3. Adornato B. T., O'Brien J. S., Lampert P. W., Roe T. F., Neustein H. B. Cerebral spongy degeneration of infancy. A biochemical and ultrastructural study of affected twins. Neurology. 1972 Feb;22(2):202–210. doi: 10.1212/wnl.22.2.202. [DOI] [PubMed] [Google Scholar]
  4. BIRNBAUM S. M., LEVINTOW L., KINGSLEY R. B., GREENSTEIN J. P. Specificity of amino acid acylases. J Biol Chem. 1952 Jan;194(1):455–470. [PubMed] [Google Scholar]
  5. Kaback M., Lim-Steele J., Dabholkar D., Brown D., Levy N., Zeiger K. Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network. JAMA. 1993 Nov 17;270(19):2307–2315. [PubMed] [Google Scholar]
  6. Kaul R., Balamurugan K., Gao G. P., Matalon R. Canavan disease: genomic organization and localization of human ASPA to 17p13-ter and conservation of the ASPA gene during evolution. Genomics. 1994 May 15;21(2):364–370. doi: 10.1006/geno.1994.1278. [DOI] [PubMed] [Google Scholar]
  7. Kaul R., Casanova J., Johnson A. B., Tang P., Matalon R. Purification, characterization, and localization of aspartoacylase from bovine brain. J Neurochem. 1991 Jan;56(1):129–135. doi: 10.1111/j.1471-4159.1991.tb02571.x. [DOI] [PubMed] [Google Scholar]
  8. Kaul R., Gao G. P., Balamurugan K., Matalon R. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease. Nat Genet. 1993 Oct;5(2):118–123. doi: 10.1038/ng1093-118. [DOI] [PubMed] [Google Scholar]
  9. Loeffler J. P., Behr J. P. Gene transfer into primary and established mammalian cell lines with lipopolyamine-coated DNA. Methods Enzymol. 1993;217:599–618. doi: 10.1016/0076-6879(93)17091-i. [DOI] [PubMed] [Google Scholar]
  10. Matalon R., Kaul R., Casanova J., Michals K., Johnson A., Rapin I., Gashkoff P., Deanching M. SSIEM Award. Aspartoacylase deficiency: the enzyme defect in Canavan disease. J Inherit Metab Dis. 1989;12 (Suppl 2):329–331. doi: 10.1007/BF03335413. [DOI] [PubMed] [Google Scholar]
  11. Matalon R., Kaul R., Michals K. Canavan disease: biochemical and molecular studies. J Inherit Metab Dis. 1993;16(4):744–752. doi: 10.1007/BF00711906. [DOI] [PubMed] [Google Scholar]
  12. Matalon R., Michals K., Gashkoff P., Kaul R. Prenatal diagnosis of Canavan disease. J Inherit Metab Dis. 1992;15(3):392–394. doi: 10.1007/BF02435985. [DOI] [PubMed] [Google Scholar]
  13. Matalon R., Michals K., Sebesta D., Deanching M., Gashkoff P., Casanova J. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. Am J Med Genet. 1988 Feb;29(2):463–471. doi: 10.1002/ajmg.1320290234. [DOI] [PubMed] [Google Scholar]
  14. Orita M., Suzuki Y., Sekiya T., Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989 Nov;5(4):874–879. doi: 10.1016/0888-7543(89)90129-8. [DOI] [PubMed] [Google Scholar]
  15. Ozand P. T., Gascon G. G., Dhalla M. Aspartoacylase deficiency and Canavan disease in Saudi Arabia. Am J Med Genet. 1990 Feb;35(2):266–268. doi: 10.1002/ajmg.1320350224. [DOI] [PubMed] [Google Scholar]
  16. Paw B. H., Tieu P. T., Kaback M. M., Lim J., Neufeld E. F. Frequency of three Hex A mutant alleles among Jewish and non-Jewish carriers identified in a Tay-Sachs screening program. Am J Hum Genet. 1990 Oct;47(4):698–705. [PMC free article] [PubMed] [Google Scholar]
  17. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ungar M., Goodman R. M. Spongy degeneration of the brain in Israel: a retrospective study. Clin Genet. 1983 Jan;23(1):23–29. doi: 10.1111/j.1399-0004.1983.tb00432.x. [DOI] [PubMed] [Google Scholar]